Press Release
Press Release
Press Contacts: Erik Cummins, Matt Hyams, Taina Rosa, Olivia Thomas
03.16.20
San Francisco-based medical genetics firm Invitae has purchased artificial intelligence software company Diploid for about $95 million.
Leuven, Belgium-based Diploid has developed an AI software called Moon, which seeks to diagnose rare diseases based on next-generation sequencing data and patient information. The purchase price consists of $32 million in cash and $63 million in common stock.
A team of Pillsbury San Diego partners Mike Hird, Richard Blaylock, Gabriella Lombardi, Peter Elias and associates Dusty Wolverton, Margaret Beale-Wirsing, Julie Park and Charmaine Lindley advised Invitae on the Diploid acquisition.